One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Contents
doi : 10.1016/S0161-6420(21)00541-8
Volume 128, Issue 10, October 2021, Pages A7, A8, A11, A14, A16
This Issue at a Glance
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.08.004
Volume 128, Issue 10, October 2021, Page 1375
A Simple Vista en Este Número
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.08.014
Volume 128, Issue 10, October 2021, Pages e1-e2
????
SandeepRavindranPhD
doi : 10.1016/j.ophtha.2021.08.007
Volume 128, Issue 10, October 2021, Page e3
A Revision of the International Classification of Retinopathy of Prematurity
Michael X.RepkaMD, MBA
doi : 10.1016/j.ophtha.2021.07.014
Volume 128, Issue 10, October 2021, Pages 1381-1383
Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study
KimberleyYuBA1VatineeBunyaMD, MSCE2MaureenMaguirePhD2PennyAsbellMD3Gui-ShuangYingPhD2Dry Eye Assessment and Management Study Research Group?
doi : 10.1016/j.ophtha.2021.03.030
Volume 128, Issue 10, October 2021, Pages 1384-1392
The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
ZhiSohMPH12MarcoYuPhD1Bjorn KaijunBetzlerMBBS2ShivaniMajithiaOD1SahilThakurMS1Yih ChungThamPhD13Tien YinWongMD, PhD13TinAungPhD, FRCS (Ed)123David S.FriedmanMD, PhD4Ching-YuChengMD, PhD123
doi : 10.1016/j.ophtha.2021.04.009
Volume 128, Issue 10, October 2021, Pages 1393-1404
Subconjunctival Silicone Oil Causing Giant Papillary Conjunctivitis
SamWilkinsonBAEricWeinlanderMDAmyLinMD
doi : 10.1016/j.ophtha.2021.03.002
Volume 128, Issue 10, October 2021, Page 1404
Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients
JackPhuMPH, PhD12MichaelKalloniatisMScOptom, PhD12
doi : 10.1016/j.ophtha.2021.03.014
Volume 128, Issue 10, October 2021, Pages 1405-1416
Teprotumumab for Asymmetric Thyroid Eye Disease
ShoaibUgradarMD1YaoWangMD2RaymondDouglasMD, PhD2
doi : 10.1016/j.ophtha.2021.03.004
Volume 128, Issue 10, October 2021, Page 1416
The Effect of Transitioning from SITA Standard to SITA Faster on Visual Field Performance
Alex T.PhamBS1Pradeep Y.RamuluMD, PhD1Michael V.BolandMD, PhD2JithinYohannanMD, MPH1
doi : 10.1016/j.ophtha.2021.03.032
Volume 128, Issue 10, October 2021, Pages 1417-1425
OCT Angiography Artifacts in Glaucoma
AlirezaKamalipourMD1SasanMoghimiMD1HuiyuanHouMD, PhD1Rafaella C.PenteadoMD1Won HyukOhMD1James A.ProudfootMSc1NevinEl-NimriPhD1ErenEkiciMD1JasminRezapourMD1Linda M.ZangwillPhD1ChristopherBowdPhD1Robert N.WeinrebMD1
doi : 10.1016/j.ophtha.2021.03.036
Volume 128, Issue 10, October 2021, Pages 1426-1437
Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy
David H.AbramsonMDY. PierreGobinMDJasmine H.FrancisMD
doi : 10.1016/j.ophtha.2021.03.018
Volume 128, Issue 10, October 2021, Page 1437
Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US
Nisha A.MalhotraMPH1Tyler E.GreenleeDO23Amogh I.IyerBS2Thais F.ContiMD2Andrew X.ChenBSE12Rishi P.SinghMD12
doi : 10.1016/j.ophtha.2021.03.010
Volume 128, Issue 10, October 2021, Pages 1438-1447
Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not “1 and Done”
Victor H.GonzalezMD1Pin-wenWangPhD2Carlos QuezadaRuizMD23
doi : 10.1016/j.ophtha.2019.08.010
Volume 128, Issue 10, October 2021, Pages 1448-1457
All Patients Treated for Proliferative Diabetic Retinopathy Need to Be Monitored Carefully over Time for Further Treatment
Michael J.ElmanMD
doi : 10.1016/j.ophtha.2021.07.019
Volume 128, Issue 10, October 2021, Pages 1458-1459
Subretinal Crystalline Lens Dislocation following Cataract Couching
WilfriedMinvielleMD1Pierre-RaphaëlRothschildMD, PhD1MathieuLehmannMD1
doi : 10.1016/j.ophtha.2021.03.021
Volume 128, Issue 10, October 2021, Page 1459
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 Years
Albert M.MaguireMD12StephenRussellMD3Daniel C.ChungDO, MA4Zi-FanYuScD5AmyTillmanMS5Arlene V.DrackMD3FrancescaSimonelliMD6Bart P.LeroyMD, PhD78Kathleen Z.ReapeMD4Katherine A.HighMD4JeanBennettMD, PhD12
doi : 10.1016/j.ophtha.2021.03.031
Volume 128, Issue 10, October 2021, Pages 1460-1468
Multifocal and Accommodating Intraocular Lenses for the Treatment of Presbyopia: A Report by the American Academy of Ophthalmology
Julie M.SchallhornMD1Seth M.PantanelliMD, MS2Charles C.LinMD3Zaina N.Al-MohtasebMD4Walter AllanSteiglemanIIIMD5Marcony R.SanthiagoMD6Timothy W.OlsenMD7Stephen J.KimMD8Aaron M.WaiteMD9Jennifer R.Rose-NussbaumerMD110
doi : 10.1016/j.ophtha.2021.03.013
Volume 128, Issue 10, October 2021, Pages 1469-1482
International Classification of Retinopathy of Prematurity, Third Edition
Michael F.ChiangMD1Graham E.QuinnMD, MSCE2Alistair R.FielderFRCP3Susan R.OstmoMS4R.V.Paul ChanMD5AudinaBerrocalMD6GilBinenbaumMD, MSCE2MichaelBlairMD78J.Peter CampbellMD, MPH4AntonioCaponeJr.MD9YiChenMD10ShuanDaiMD11AnnaEllsMD12Brian W.FleckMD13William V.GoodMD14M.Elizabeth HartnettMD15GerdHolmstromMD, PhD16ShunjiKusakaMD, PhD17AndrésKychenthalMD18DomenicoLeporeMD19BirgitLorenzMD, PhD2021Maria AnaMartinez-CastellanosMD22?engülÖzdekMD23DupeAdemola-PopoolaMD24James D.ReynoldsMD25Parag K.ShahMD26MichaelShapiroMD7AndreasStahlMD27CynthiaTothMD28AnandVinekarMD, PhD29LindaVisserMD30David K.WallaceMD, MPH31Wei-ChiWuMD, PhD32PeiquanZhaoMD33AndreaZinMD, PhD34
doi : 10.1016/j.ophtha.2021.05.031
Volume 128, Issue 10, October 2021, Pages e51-e68
COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses
David S.PortneyBS1ZiweiZhuMS2Evan M.ChenBS3EmmaSteppeMPH2PriyankaChilakamarriMD45Maria A.WoodwardMD, MSc12ChadEllimoottilMD, MS26RaviParikhMD, MPH78
doi : 10.1016/j.ophtha.2021.02.010
Volume 128, Issue 10, October 2021, Pages 1483-1485
Changes in Medicare Reimbursement for Commonly Performed Ophthalmic Procedures
ShrijiPatelMD1DavidGlasserMD2Michael X.RepkaMD2SeanBerkowitzBS3PaulSternbergJr.MD1
doi : 10.1016/j.ophtha.2021.02.026
Volume 128, Issue 10, October 2021, Pages 1485-1487
Litigation in Ophthalmology against the National Health Service in England
VaroKirthiMD, MRCP12James E.NeffendorfMD, FRCOphth13Annakan V.NavaratnamMD, FRCS4John T.MachinMD, FRCS4MelanieHingoraniMD, FRCOphth5Timothy W.R.BriggsMD, FRCS4AlisonDavisMD, FRCOphth45CarolineMacEwenMD, FRCOphth4Timothy L.JacksonPhD, FRCOphth12
doi : 10.1016/j.ophtha.2021.03.028
Volume 128, Issue 10, October 2021, Pages 1487-1489
OCT Angiography Findings in Preclinical Alzheimer’s Disease: 3-Year Follow-Up
Bliss ElizabethO’BryhimMD, PhD1Jonathan B.LinMD, PhD12Gregory P.Van StavernMD1Rajendra S.ApteMD, PhD1
doi : 10.1016/j.ophtha.2021.02.016
Volume 128, Issue 10, October 2021, Pages 1489-1491
Re: Heier et al.: Intravitreal combined aflibercept + anti–platelet-derived growth factor receptor ? for neovascular age-related macular degeneration: results of the phase 2 CAPELLA trial (Ophthalmology. 2020;127:211–220)
MarkNelsonMD
doi : 10.1016/j.ophtha.2021.03.038
Volume 128, Issue 10, October 2021, Pages e69-e70
Reply
David M.BrownMD
doi : 10.1016/j.ophtha.2021.03.039
Volume 128, Issue 10, October 2021, Page e70
Re: Li et al.: Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study (Ophthalmology. 2021;128:1180-1187)
YuexinWangMD
doi : 10.1016/j.ophtha.2021.05.024
Volume 128, Issue 10, October 2021, Pages e70-e72
Reply
Xiu JuanZhangPhD1YuzhouZhangMSc1Benjamin Hon KeiYipPhD2Jason C.YamFCOphth1
doi : 10.1016/j.ophtha.2021.05.025
Volume 128, Issue 10, October 2021, Page e72
